Compliance Monitoring, Audit & Risk Oversight 2020 | Informa Connect | 10 February 2020 | Hilton Philadelphia at Penn’s Landing, 201 S. Christopher Columbus Boulevard Philadelphia, PA 19106

What to Expect
• Identify and Mitigate High-Priority Risk Areas
• Speaker Programs
• Patient Interactions
• Publications
• Payer communications
• Patient Support and Assistance Programs
• HCP Engagement And more!

Discover Real-World Applications of Data Analytics and AI
Master Class A: Beginner Level — Artificial Intelligence and Anti-Fraud Data Analytics
Master Class B: Intermediate/Advanced Level — Building Up Analytics for Better Insights Across the Organization

Who Should Attend
You will benefit from attending this meeting if you work at a pharmaceutical, biotech or medical device company with involvement or responsibility for:
• Compliance & Ethics
• Compliance Monitoring
• Legal/Counsel
• Internal Audit
• Operations/Testing
• Reporting/Assurance
• Business/Internal Controls
• IT
• Finance
• Due Diligence
• Risk Management/Enterprise Risk Management (ERM)
• Oversight
• Anti-Bribery and Anti-Corruption (ABAC)
• Third-Party

2020 Speakers

ISHA ARORA
Founder, CEO at INGEN, LLC

Desiree Auchey
Associate Director, Novartis Pharmaceuticals Corporation

Marvin Autrey
Ethics & Compliance RMO – Audit & Monitoring, Novartis

Michael Briganti
Director, International Risk Management, Bristol-Myers Squibb

Andrew Caffrey, III
Assistant U.S. Attorney, Civil Healthcare Fraud Coordinator, U.S. Attorney’s Office, District of New Jersey

Don Carter
Associate Director, Compliance, TESARO (now GlaxoSmithKline)

MD Neon Chowdhury
Director, PwC

Corey Dunbar
Senior Manager, Forensic & Integrity Services, Ernst & Young LLP

Eren Efe
Senior Manager, Compliance Auditing & Monitoring, Becton Dickinson

David Eskew
Chief, Health Care & Government Fraud Unit, U.S. Attorney’s Office, District of New Jersey

Fred Gibbons
Senior Manager, Analytics, Deloitte LLP

Baris Goc
Director, PwC

David Gonzalez
Senior Manager, Forensic & Integrity Services, Ernst & Young LLP

Marie Hendrixson
Vice President, Internal Audit, Teleflex

Lauren Hickson
Associate Director, Compliance Monitoring and Analytics, Allergan

Franco Kakiko
Director, Internal Audit, Daiichi Sankyo Inc.

Paul Kaufman
Assistant U.S. Attorney, Civil Division, U.S. Attorney’s Office, Eastern District of Pennsylvania

Seth Lundy
Partner, FDA and Life Sciences, King & Spalding

George Mina
Senior Director – International Compliance Monitoring, Pfizer Inc.

Vahan Minassian
Director, U.S. Promotional Monitoring Lead, Pfizer Inc

Mohammad Ovais
CEO, qordata

Michael O’Connor
VP, Compliance Technology, CTO, Porzio Life Sciences LLC

Stephen Panarese
Senior Manager, PwC

Kathryn Pryze
Compliance Senior Manager, Monitoring, Endo Pharmaceuticals

David Ralston
Senior Associate General Counsel, Gilead

Shawn Reardon
President, Independent Commercial Compliance

Roberta Rima, CFE
Director, Internal Audit, Gilead

Brooke Sherer
Director, Compliance Counsel, Regeneron

Harold Silverman, CIA, QIAL, CRMA
Managing Director of CAE Services, The Institute of Internal Auditors

Jerel Smith
Associate Director, Compliance Operations, Otsuka Pharmaceutical Companies (U.S.)

Kiley Smith Kelly
Principal, Forensic & Integrity Services, Ernst & Young LLP

W. Anson Tinney, III
Sr. Specialist, Data Analytics and Transparency, Merck

Kathleen Veit
Vice President, Global Compliance, Investigations & Monitoring, Teva Pharmaceuticals

Mario Velichkov
Associate Director, Data Analytics and Risk Systems, Novartis Pharmaceuticals Corporation

Christina Woods
Director, PwC

2020 Sponsors and Partners

• Potomac River Partners
• Independent Commercial
• Qordata
• Porzio Bromberg&Newman P.C
• Porzio LifeSciences
• PWC Price Waterhouse
• TrialCard
• EY Building a better working world
• Centerfirst Ecery Contact Matters
• Cresen Solutions Complexity Simplified

MEDIA PARTNERS:
• Pharmaceutical Executive
• Corporate Compliance Insights
• Policy and Medicine
• Pharmaceutical Commerce
• Pharma Voice
• Radical Compliance